Skip to main content
. 2021 Jun 7;17(1):185–193. doi: 10.4103/1673-5374.314312

Figure 5.

Figure 5

Effect of Alda-1 on locomotor function. Locomotor function was assessed using the BMS scale at indicated days.

An observer, blinded to groups, evaluated the BMS. A score of 9 on the BMS scale was assigned to sham animals displaying coordinated gait, consistent toe clearance, lifted tail and steady trunk. Data are presented as the mean ± SD (n = 7).***P < 0.001, vs. SCI (one-way analysis of variance with Tukey’s post hoc test). Alda-1: N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide; BMS: Basso Mouse Scale; SCI: spinal cord injury.